8-K: Acadia Healthcare Reports Strong Q3 2024 Results and Updates Full-Year Guidance

Acadia Healthcare announced strong third-quarter results with revenue growth and increased adjusted EBITDA, while also revising its full-year 2024 financial guidance.

Summary

• Acadia Healthcare reported a revenue of $815.6 million for the third quarter of 2024, an 8.7% increase compared to the same period in 2023.
• Same facility revenue grew by 8.6%, driven by a 3.6% increase in revenue per patient day and a 4.7% increase in patient days.
• Net income attributable to Acadia was $68.1 million, or $0.74 per diluted share, while adjusted income was $84.1 million, or $0.91 per diluted share.
• Adjusted EBITDA reached $194.3 million, a 10.5% increase year-over-year, with a same facility adjusted EBITDA margin of 29.7%, a 100 bps increase.
• The company added 15 beds to existing facilities and opened five new CTCs in the third quarter, bringing the total to 164 CTCs across 32 states.
• Acadia is on track to open up to 14 new CTCs and over 400 new beds at existing facilities for the full year, with over 300 beds expected in the fourth quarter.
• The company also expects to complete construction on nearly 700 new beds in the fourth quarter, including joint venture hospitals and a new facility in Madison, Wisconsin.
• Acadia revised its 2024 revenue guidance to $3.150 to $3.165 billion, adjusted EBITDA to $725 to $735 million, and adjusted earnings per diluted share to $3.35 to $3.45.
• The revised guidance reflects the closure of two facilities during the third quarter, which were previously expected to contribute $17 million in revenue and $1 million in EBITDA in the second half of the year.
• As of September 30, 2024, Acadia had $82.1 million in cash and cash equivalents and $321.5 million available under its revolving credit facility, with a net leverage ratio of approximately 2.5x.

Sentiment

Score: 7

Explanation: The sentiment is positive due to strong Q3 results and continued growth, but tempered by the revised guidance and facility closures. The company is executing well on its strategy, but faces some challenges.

Positives

• Acadia demonstrated strong revenue growth in the third quarter, with an 8.7% increase year-over-year.
• The company achieved significant growth in same facility revenue, driven by both increased patient days and revenue per patient day.
• Adjusted EBITDA showed a healthy increase of 10.5%, indicating improved profitability.
• Acadia is actively expanding its capacity by adding beds to existing facilities and opening new CTCs.
• The company is on track to meet its expansion goals for the year, with a substantial number of new beds expected in the fourth quarter.
• Acadia maintains a strong financial position with a healthy cash balance and available credit.

Negatives

• The company closed two facilities during the third quarter, which negatively impacted the full-year guidance.
• The revised full-year guidance reflects a reduction in expected revenue and EBITDA due to the facility closures.
• The number of new beds available by the end of the fourth quarter is subject to the timing of state-issued licenses, which introduces some uncertainty.

Risks

• The company faces potential difficulties in integrating acquired facilities and realizing the benefits of expansions and joint ventures.
• There is a risk of potential reductions in payments from government and commercial payors.
• Patient incidents, governmental investigations, litigation, and adverse regulatory actions could negatively impact the company.
• Acadia may not generate sufficient cash from operations to service its debt and meet its capital expenditure requirements.
• Disruptions to information technology systems or cybersecurity incidents pose a risk.
• Operating difficulties, including economic downturns, reduced admissions, increased costs, and changes in competition, could affect the company's performance.

Future Outlook

Acadia revised its full-year 2024 financial guidance, reflecting the closure of two facilities, but remains focused on strategic growth objectives, including facility expansions and new CTC openings. The company anticipates completing construction on approximately 1,200 beds, with approximately 1,000 expected to be licensed and available by year-end.

Management Comments

• Chris Hunter, Chief Executive Officer of Acadia Healthcare Company, remarked, 'Our financial results for the third quarter of 2024 reflect continued execution of our growth strategy.'
• He also stated, 'We have the scale and expertise to support patients across the continuum of care.'
• He further added, 'We are proud of the important work we are doing and are committed to providing safe, quality care for the patients, families and communities we serve while creating long-term value for our stockholders.'

Industry Context

Acadia's performance reflects the ongoing demand for behavioral healthcare services. The company's expansion strategy, including new facilities and joint ventures, aligns with the industry trend of increasing access to care. The revised guidance, while impacted by facility closures, still indicates a positive outlook for the company's growth trajectory.

Comparison to Industry Standards

• Acadia's 8.7% revenue growth in Q3 2024 is strong compared to the broader healthcare sector, which has seen moderate growth.
• The 10.5% increase in adjusted EBITDA is also a positive indicator of operational efficiency and profitability, outperforming many of its peers in the behavioral health space.
• Companies like Universal Health Services (UHS) and HCA Healthcare, while larger, have shown similar growth patterns in their behavioral health divisions, but Acadia's focus on stand-alone behavioral health gives it a unique position.
• Acadia's expansion plans, including the addition of 1,200 beds, are aggressive and aim to capture a larger share of the growing behavioral health market, similar to the expansion strategies of other large healthcare providers.
• The adjusted EBITDA margin of 29.7% for same facilities is competitive, indicating strong pricing power and cost management compared to industry averages.

Stakeholder Impact

• Shareholders will likely react positively to the strong Q3 results and growth prospects, but may be cautious due to the revised guidance.
• Employees will continue to be part of a growing organization with opportunities for advancement.
• Patients will benefit from increased access to behavioral healthcare services through facility expansions.
• Suppliers will see continued demand for their products and services.
• Creditors will be reassured by the company's strong financial position and cash flow.

Next Steps

• Acadia will hold a conference call on October 31, 2024, to discuss the third-quarter results.
• The company will continue to focus on expanding its facilities and opening new CTCs.
• Acadia will work to obtain the necessary state licenses for the new beds expected to be available by the end of the year.

Key Dates

Keywords

Acadia Healthcare, Behavioral Healthcare, Financial Results, Third Quarter, Guidance, EBITDA, Revenue, CTC, Facility Expansion, Net Income